5HIAA as a marker for anti-vascular activity. CTNZ_04_3
Registration number:
|
ACTRN12605000459628 |
Ethics number:
|
AKY/04/11/315 |
This is a pilot study where scientists and clinicians are exploring the clinical
application of blood markers (serum 5HIAA) associated with endothelial damage during
anti-cancer therapy. The study involves cancer patients who are planned to recieve
chemotherapy and a group of healthy volunteers.
Progress
This trial closed to recruitment in July 2009 with a total of 29 subjects entered.
Results
None to date
Centres involved
-
The University of Auckland
